Loading clinical trials...
Loading clinical trials...
Prevalence of Neuroendocrine Dysfunction in the Pediatric Cardiopulmonary Bypass Patient
The goal of this study is to evaluate specific hormone levels in children undergoing heart surgery in order to identify patterns associated with any unstable vital signs. The data collected will provide preliminary answers to the question "Are hormone values a determining factor for drug administration and dosing levels?" and help establish the benefits of routine steroid and hormone administration. Sixty subjects will be enrolled. Blood samples will be drawn before the surgery,and again nine hours after surgery for analysis. Other patient data such as medications, vital signs, routine lab values and treatments will also be analyzed. As our current standard of care includes routine doses of steroids, we believe this study will increase our general knowledge and improve the care of these critically ill children. The study will also provide the foundation needed for grant support from the American Heart Association, allowing for future larger scale studies.
Age
0 - 1 years
Sex
ALL
Healthy Volunteers
No
Children's Healthcare of Atlanta at Egleston
Atlanta, Georgia, United States
Start Date
March 1, 2009
Primary Completion Date
October 1, 2009
Completion Date
October 1, 2009
Last Updated
January 7, 2014
3
ACTUAL participants
Blood draws
OTHER
Lead Sponsor
Emory University
Collaborators
NCT05647213
NCT07042334
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions